Member Info for Timster

Didn't honest Al say there was no data that existed for volume of straight dox in tumours.

Watch the whole of that presentation is pretty incredible data. Does make you wonder where the BP's are. Phase 2 efficacy study with a specific indication may peak their interest perhaps.

Unbreaded not Unneeded

Unneeded " I would love to hear “log 2 higher in TME than plasma AND close to the straight dox conc in the TME."

https://avacta.wistia.com/medias/ht4xpiwakz

17 mins onwards

"And so what we're seeing is regardless of FAP high or FAP mid expression in the tumor microenvironment, we see a two log difference between the blood concentration and the tumor concentration."

Nah, professor eggy, says no....

Hopefully the 3 cohorts is enough for 2 weekly dosing and they just crack on now. We should find out soon.

Means only 1 thing!!!! Watch the bid

Someone knows something....

Poor old tucandoom must have had a cardiac today over all the pom pom waving from a photo change on the website.

"Gee man I Wouldn’t want to be out this over the weekend!"

Not after that picture update, explosive start Monday!!

The yanks will love those bollards, watch the bid, size buyers in charge.

This is brilliant, speculation on a photo change.

Looks to me like she's carrying a suitcase with £8bn in it, clearly off to the bank.

This pom pom waving ramping is ridiculous!!

£200 ex chi-nah is a while away yet right after the Eli lilly/AZN take over battle when they are back off their holidays in September.

£8

It's funny that a thread titled "Nanoparticles and AVA6000" has hundreds of replies as it's Hurstbot garbage which had nothing to do with ava6000

Don't look now, there's been a leeke massive AZN buyout on the cards, watch the bid, NY loving it.

It's not going to be December, I was just pointing out that's still H2.

News in the next few weeks I'd imagine.

Still H2 LDA

CC could deliver in December and she's still honour the 100% on target for H2.

Hopefully we'll here something about something before then though.

The two are completely unrelated Hurstbot, other than being treatments for cancer.

Phase 2 is when they will choose specific indications to test efficacy.

Safety and tolerability has been proven beyond doubt.

Because they fit the criteria and this stage of the trial is nothing to do with efficacy.

Although it has been seen.